Sinopharm
1099.HK
#1997
Rank
โ‚น676.95 B
Marketcap
โ‚น216.93
Share price
0.73%
Change (1 day)
-3.72%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.089 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.333 Trillion. an increase over the revenue in the year 2022 that were of โ‚น6.956 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 โ‚น7.333 T5.42%
2022 โ‚น6.956 T-2.1%
2021โ‚น7.105 T16.85%
2020โ‚น6.080 T14.95%
2019โ‚น5.290 T21.52%
2018โ‚น4.353 T5.93%
2017โ‚น4.109 T27.22%
2016โ‚น3.230 T5.37%
2015โ‚น3.065 T9.14%
2014โ‚น2.808 T17.22%
2013โ‚น2.395 T25.94%
2012โ‚น1.902 T34.61%
2011โ‚น1.413 T55.34%
2010โ‚น909.82 B35.79%
2009โ‚น670.03 B37.56%
2008โ‚น487.09 B31.43%
2007โ‚น370.62 B40.26%
2006โ‚น264.23 B